[1] ZHANG Y Y, MCNEILL E, TIAN H, et al. Urine derived cells are a potential source for urological tissue reconstruction[J]. J Urol, 2008, 180(5):2226-2233. [2] CULENOVA M, NICODEMOU A, NOVAKOVA Z V, et al. Isolation, culture and comprehensive characterization of biological properties of human urine-derived stem cells[J]. Int J Mol Sci, 2021, 22(22):12503. [3] BURDEYRON P, GIRAUD S, HAUET T, et al. Urine-derived stem/progenitor cells:a focus on their characterization and potential[J]. World J Stem Cells, 2020, 12(10):1080-1096. [4] 沈亮亮, 周明, 谯英固, 等. 人尿源性干细胞组织来源与多向应用研究进展[J]. 临床泌尿外科杂志, 2019, 34(9):745-748. [5] BENTO G, SHAFIGULLINA A K, RIZVANOV A A, et al. Urine-derived stem cells:applications in regenerative and predictive medicine[J]. Cells, 2020, 9(3):573. [6] NABHAN A N, BROWNFIELD D G, HARBURY P B, et al. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells[J]. Science, 2018, 359(6380):1118-1123. [7] BHARADWAJ S, LIU G H, SHI Y G, et al. Multipotential differentiation of human urine-derived stem cells:potential for therapeutic applications in urology[J]. Stem Cells, 2013, 31(9):1840-1856. [8] 国家药典委员会. 中华人民共和国药典(2020年版:一部)[M]. 北京:中国医药科技出版社, 2020:340. [9] 刘松, 刘超明, 赖丽娟, 等. 淫羊藿素的药理作用研究进展[J]. 赣南医学院学报, 2017, 37(4):631-635. [10] YANG X J, XI Y M, LI Z J. Icaritin:a novel natural candidate for hematological malignancies therapy[J]. Biomed Res Int, 2019, 2019:4860268. [11] 翟远坤, 李志忠, 陈克明, 等. 淫羊藿素和脱水淫羊藿素对骨髓间充质干细胞成骨性分化影响的比较研究[J]. 中国药学杂志, 2011, 46(11):837-842. [12] 赵曙炎, 马泽云. 脱水淫羊藿素促进骨髓间质干细胞修复裸鼠临界性颅骨缺损的实验研究[J]. 黑龙江医学, 2016, 40(6):490-492. [13] 周明, 孙震晓. 人尿源性干细胞的原代培养[J]. 癌变·畸变·突变, 2017, 29(5):390-393. [14] ZHOU M, SHEN L L, QIAO Y G, et al. Inducing differentiation of human urine-derived stem cells into hepatocyte-like cells by coculturing with human hepatocyte L02 cells[J]. J Cell Biochem, 2020, 121(1):566-573. [15] SATO N, MEIJER L, SKALTSOUNIS L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor[J]. Nat Med, 2004, 10(1):55-63. [16] 李佳玮, 张密霞, 周涛, 等. 人参皂苷Rg1干预骨髓间充质干细胞转化为多潜能干细胞关键基因mRNA的表达[J]. 中国组织工程研究与临床康复, 2011, 15(32):6032-6035. [17] LEE J, GO Y, KANG I, et al. Oct-4 controls cell-cycle progression of embryonic stem cells[J]. Biochem J, 2010, 426(2):171-181. [18] CRUCIANI S, SANTANIELLO S, MONTELLA A, et al. Orchestrating stem cell fate:novel tools for regenerative medicine[J]. World J Stem Cells, 2019, 11(8):464-475. [19] 沈亮亮, 李勇, 周明, 等. 增强人尿源性干细胞干性的中药小分子活性成分筛选[J]. 中国新药杂志, 2020, 29(24):2839-2845. [20] HUANG P, LI Y B, NASSER M I, et al. Urine-derived induced pluripotent stem cells in cardiovascular disease[J]. Cardiol Res Pract, 2020, 2020:3563519. [21] ZHANG W Q, HU J G, HUANG Y Z, et al. Urine-derived stem cells:applications in skin, bone and articular cartilage repair[J]. Burns Trauma, 2021, 9:tkab039. [22] SATO M, TAKIZAWA H, NAKAMURA A, et al. Application of urine-derived stem cells to cellular modeling in neuromuscular and neurodegenerative diseases[J]. Front Mol Neurosci, 2019, 12:297. [23] 谢振华, 吴耀炯. 主要干性基因与衰老相关基因表达水平的相互拮抗关系[J]. 生物化学与生物物理进展, 2014, 41(7):627-631. [24] TSANG W P, ZHANG F J, HE Q L, et al. Icaritin enhances mESC self-renewal through upregulating core pluripotency transcription factors mediated by ERα[J]. Sci Rep, 2017, 7:40894. [25] WANG L, LI S, WANG H Y, et al. In a rat model of acute liver failure, icaritin improved the therapeutic effect of mesenchymal stem cells by activation of the hepatocyte growth factor/c-met pathway[J]. Evid Based Complement Alternat Med, 2019, 2019:4253846. [26] SHARMA M, FONSECA F P, HUNTER K D, et al. Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation[J]. Int J Oral Sci, 2020, 12:23. [27] JI X L, WANG M, CHEN F, et al. Urine-derived stem cells:the present and the future[J]. Stem Cells Int, 2017, 2017:4378947. [28] REN Y B, HUANG J H, CAI W J, et al. Shen-Jing as a Chinese medicine concept might Be a counterpart of stem cells in regenerative medicine[J]. Chin J Integr Med, 2019, 25(1):64-70. [29] 张金生, 张宝霞. "肾精"与"干细胞"的同一性认识[J]. 中华中医药学刊, 2018, 36(2):326-328. [30] 郭俊霞, 王晓宇, 吴萍, 等. 基于药材质量研究的淫羊藿本草源流考[J]. 亚太传统医药, 2022, 18(5):189-194. [31] 张爱娟, 王汉裕, 许放, 等. 淫羊藿素对人脐带间充质干细胞增殖与细胞因子分泌的影响[J]. 中药新药与临床药理, 2017, 28(2):159-164. [32] 项国梁, 陈跃平, 卓映宏. 淫羊藿苷调控骨髓间充质干细胞相关分化机制及应用研究进展[J]. 中国中西医结合杂志, 2020, 40(8):1019-1024. [33] 李烨, 肖亚平, 李晶晶, 等. 淫羊藿对骨髓间充质干细胞影响的研究进展[J]. 中国药学杂志, 2017, 52(24):2137-2140. [34] 高巳东, 邓洋洋, 王重一, 等. 淫羊藿苷与雌激素对大鼠骨髓间充质干细胞成骨分化的影响[J]. 中国骨质疏松杂志, 2022, 28(2):174-177, 191. [35] 宣守松, 罗志荣, 李涵, 等. 淫羊藿苷联合白藜芦醇促进诱导性多能干细胞向心肌细胞分化的作用及机制研究[J]. 中国中医药信息杂志, 2020, 27(8):57-62. |